Arabilin overcomes resistance to AR-targeted therapy

J Antibiot (Tokyo). 2017 Mar;70(3):328-330. doi: 10.1038/ja.2016.162. Epub 2017 Jan 11.

Authors

Takahiro Fujimaki¹, Shun Saito¹, Masaya Imoto¹

Affiliation

¹ Department of Biosciences and Informatics, Faculty of Science and Technology, Keio University, Yokohama, Japan.

PMID: 28074047
DOI: 10.1038/ja.2016.162

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Androgen Receptor Antagonists / pharmacology*
Cell Line, Tumor
Humans
Male
Prostatic Neoplasms / drug therapy
Pyrones / pharmacology*

Substances

Androgen Receptor Antagonists
Pyrones
arabilin